Great Point Partners as of Dec. 31, 2023
Portfolio Holdings for Great Point Partners
Great Point Partners holds 34 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences (ALPN) | 12.0 | $71M | 3.7M | 19.06 | |
| Cytokinetics Com New (CYTK) | 7.1 | $42M | 500k | 83.49 | |
| Urogen Pharma (URGN) | 6.7 | $39M | 2.6M | 15.00 | |
| Pliant Therapeutics (PLRX) | 5.6 | $33M | 1.8M | 18.11 | |
| Ultragenyx Pharmaceutical (RARE) | 5.3 | $31M | 648k | 47.82 | |
| Xenon Pharmaceuticals (XENE) | 4.7 | $28M | 600k | 46.06 | |
| Rapt Therapeutics (RAPT) | 4.7 | $27M | 1.1M | 24.85 | |
| Alkermes SHS (ALKS) | 4.1 | $24M | 875k | 27.74 | |
| Aerovate Therapeutics (AVTE) | 4.0 | $24M | 1.0M | 22.63 | |
| Vaxcyte (PCVX) | 3.9 | $23M | 360k | 62.80 | |
| Evolus (EOLS) | 3.6 | $21M | 2.0M | 10.53 | |
| Anaptysbio Inc Common (ANAB) | 3.6 | $21M | 977k | 21.42 | |
| Immunocore Hldgs Ads (IMCR) | 3.4 | $20M | 293k | 68.32 | |
| Neurogene (NGNE) | 3.3 | $19M | 994k | 19.38 | |
| Amicus Therapeutics (FOLD) | 3.1 | $18M | 1.3M | 14.19 | |
| Tourmaline Bio (TRML) | 3.0 | $18M | 673k | 26.18 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.8 | $17M | 1.6M | 10.70 | |
| Zura Bio Class A Ord Shs (ZURA) | 2.6 | $15M | 3.3M | 4.67 | |
| Optinose (OPTN) | 1.9 | $11M | 8.8M | 1.29 | |
| Apogee Therapeutics (APGE) | 1.9 | $11M | 400k | 27.94 | |
| Arvinas Ord (ARVN) | 1.6 | $9.6M | 234k | 41.16 | |
| Karuna Therapeutics Ord | 1.6 | $9.6M | 30k | 316.51 | |
| Vistagen Therapeutics Ord (VTGN) | 1.6 | $9.6M | 1.9M | 5.14 | |
| Terns Pharmaceuticals (TERN) | 1.4 | $8.5M | 1.3M | 6.49 | |
| Intra Cellular Therapies (ITCI) | 1.4 | $7.9M | 111k | 71.62 | |
| Sarepta Therapeutics (SRPT) | 1.3 | $7.7M | 80k | 96.43 | |
| Insmed Com Par $.01 (INSM) | 1.2 | $7.0M | 226k | 30.99 | |
| Puma Biotechnology (PBYI) | 0.8 | $4.7M | 1.1M | 4.33 | |
| Ocular Therapeutix (OCUL) | 0.5 | $3.1M | 700k | 4.46 | |
| Spyre Therapeutics Com New (SYRE) | 0.5 | $2.7M | 125k | 21.52 | |
| Arcellx Common Stock (ACLX) | 0.5 | $2.7M | 48k | 55.50 | |
| Merus N V (MRUS) | 0.1 | $550k | 20k | 27.50 | |
| Axsome Therapeutics (AXSM) | 0.1 | $395k | 5.0k | 79.59 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.0 | $68k | 12k | 5.92 |
